Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
Labrie, Fernand, Luu-The, Van, Labrie, Claude, Bélanger, Alain, Simard, Jacques, Lin, Sheng-Xiang, Pelletier, Georges·2003·Endocrine Reviews
Cited by (545)
Items 501–545 of 545
- The Passing of Dr. Fernand Labrie (1937–2019): The legacy of excellence in scienceAndré Tchernof, Sheng Xiang Lin, Van Luu-The, Jacques Simard · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
- Antiproliferative Activity of Spironolactone: In Vitro StudyMohammed A. Taher · 2018 · Iraqi Journal of Cancer and Medical Genetics
- Effects of ⧍-5 and ⧍-4 Androgens on the BrainNicola Pluchino, Andrea Riccardo Genaz zani, Gynaecologist · 2008 · touchREVIEWS in Endocrinology
- Menopause SymptomsDebra L. Barton, Sherry L. Wolf · 2010 · Springer eBooks
- Reprint of “In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3”Jenny Roy, Michelle-Audrey Fournier, René Maltais, Lucie Carolle Kenmogne, Donald Poirier · 2015 · The Journal of Steroid Biochemistry and Molecular Biology
- Testosterone Therapy and Women‗s SexualityValeria Valentino, Giovanna Simi, Chiara Naninixy · 2007 · touchREVIEWS in Endocrinology
- Regulação hormonal da prostata feminina do gerbilo da MongoliaAna Maria Galvan Custodio · 2007
- Expresión de los ARNm que codifican para las enzimas que biotransforman a la testosterona en células humanas de carcinoma mamarioLeticia González Núñez · 2007
- Stress and Androgens in Himba WomenSean P. Prall, Brooke A. Scelza, Benjamin C. Trumble · 2023 · Adaptive Human Behavior and Physiology
- The impact of menopause and serum DHEA-S level on the severity of Covid-19Cemal Tamer Erel, İpek Betül Özçivit Erkan, Neslihan Gökmen İnan · 2023 · Maturitas
- A Narrative Review of the Vascular Consequences of Estrogen Deficiency: A Focus on Female Athletes with Functional Hypothalamic AmenorrheaEmma O’Donnell, Paula Harvey · 2023 · Advances in biochemistry in health and disease
- Associations of tubal ligation and hysterectomy with serum androgen and estrogen metabolites among postmenopausal women in the Women’s Health Initiative Observational StudyAshley M. Geczik, Kara A. Michels, Garnet L. Anderson, Roni T. Falk, Leslie V. Farland, JoAnn E. Manson, Aladdin H. Shadyab, Ruth M. Pfeiffer, Xia Xu, Britton L. Trabert · 2024 · Cancer Causes & Control
- Traditional practices in CNS drug deliveryGurmeet Singh, Amandeep Singh, Rohit Bhatia, Rajveer Singh, Dilpreet Kaur, Raj Kumar Narang · 2024 · Elsevier eBooks
- 10.1016/b978-1-4160-2911-3.50021-22000 · Time to knit
- The association between androgen receptor expression and some pathological characteristics in patients with breast cancerMahdokht Azizi, Seyed Madani, Babak Izadi · 2021 · Clinical Cancer Investigation Journal
- アルドステロン研究から心臓ステロイド研究へ(4.心血管内分泌系 : アンジオテンシン受容体・アルドステロン受容体研究の新展開)(<特集II>第68回日本循環器学会学術集会)吉村 道博 · 2005 · Journal of JCS Cardiologists
- Additional file 5 of Transcriptome characterization of BPG axis and expression profiles of ovarian steroidogenesis-related genes in the Japanese sardineNyuji, Mitsuo, Hongo, Yuki, Yoneda, Michio · 2020 · Figshare
- Additional file 2 of Transcriptome characterization of BPG axis and expression profiles of ovarian steroidogenesis-related genes in the Japanese sardineNyuji, Mitsuo, Hongo, Yuki, Yoneda, Michio · 2020 · Figshare
- Additional file 8 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 5 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 11 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 10 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 9 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 12 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 6 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 14 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 15 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 4 of Transcriptome characterization of BPG axis and expression profiles of ovarian steroidogenesis-related genes in the Japanese sardineNyuji, Mitsuo, Hongo, Yuki, Yoneda, Michio · 2020 · Figshare
- Additional file 2 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 13 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 4 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 7 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 1 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- Additional file 3 of Ceritinib is a novel triple negative breast cancer therapeutic agentDong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
- NAD boosting by CD38 inhibition drives reversal of a pathological vicious cycle of intracrine activity and inflammation in eyelid meibomian gland involutionYuki Hamada, Takehide Sakamoto, Daisuke Yarimizu, Hikari Uehara, Xinyan Shao, Tom Macpherson, Emi Hasegawa, Masao Doi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- Association Between Sarcopenia Index and Central Obesity: Age- and Gender-Specific Patterns and Clinical ImplicationsYa-Hui Lee, Wen-Bin Bai, Yueh Lin, Guo-Tao Su, Wen-Cheng Li · 2026 · International Journal of General Medicine
- NAD boosting mediated by CD38 inhibition drives reversal of a pathological vicious cycle of intracrine activity and inflammation in eyelid meibomian gland dysfunctionYuki Hamada, Takehide Sakamoto, Daisuke Yarimizu, Hikari Uehara, Xinyan Shao, Tom Macpherson, Emi Hasegawa, Masao Doi · 2026 · eLife
- Rôle de la signalisation PKA dans la zonation de la glande surrénale : modèles génétiques murins et mécanismes post-traductionnelsTyphanie Dumontet · 2017 · theses.fr (ABES)
- Contribution à l’étude des mécanismes de sensibilité aux traitements antiandrogènes dans les cancers du sein moléculaires apocrinesThomas Grellety · 2018
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in AgingRebecca L. Glaser · 2026 · Cureus · Retracted
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and SafetyJuana Montero Bernaldez, Elizabeth R Burgess, Rebeca Martinez, Manuel Peñalver · 2026 · Cureus
- Near-infrared spectroscopy with chemometric analysis distinguishes genitourinary syndrome of menopause in vaginal samplesIaponira da Silva Figueiredo Vidal, Amaxsell Thiago Barros de Souza, Lidiane G. Silva · 2026 · European Journal of Obstetrics & Gynecology and Reproductive Biology
- Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment TargetsBarbara E. Licznerska, Hanna Szaefer, Hanna Sobierajska, Wanda Baer‐Dubowska · 2026 · International Journal of Molecular Sciences
- Grundlagen der parakrinen, autokrinen und intrakrinen Regulation endokriner OrganeJosef Köhrle · 2006 · Springer eBooks
- Study of women veterans in menopausePatricia A. Rouen · 2009 · Deep Blue (University of Michigan)